Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Return on Invested Capital (2016 - 2019)

IGC Pharma (IGC) has disclosed Return on Invested Capital for 9 consecutive years, with 0.08% as the latest value for Q4 2019.

  • On a quarterly basis, Return on Invested Capital changed N/A to 0.08% in Q4 2019 year-over-year; TTM through Dec 2019 was 0.08%, a N/A change, with the full-year FY2019 number at 0.04%, changed N/A from a year prior.
  • Return on Invested Capital was 0.08% for Q4 2019 at IGC Pharma, down from 0.07% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.05% in Q2 2018 to a low of 0.32% in Q2 2017.
  • A 5-year average of 0.15% and a median of 0.09% in 2016 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: fell -23bps in 2017, then surged 37bps in 2018.
  • IGC Pharma's Return on Invested Capital stood at 0.31% in 2015, then skyrocketed by 82bps to 0.06% in 2016, then plummeted by -444bps to 0.3% in 2017, then soared by 117bps to 0.05% in 2018, then tumbled by -252bps to 0.08% in 2019.
  • Per Business Quant, the three most recent readings for IGC's Return on Invested Capital are 0.08% (Q4 2019), 0.07% (Q3 2019), and 0.05% (Q2 2019).